The introduction of EWS-FLI1 into neuroblastoma, rhabdomyosarcoma, or mesenchymal stem cells turned on CD99 expression [66,67] while the silencing of EWS-FLI1 in Ewing sarcoma cells does not affect high-level CD99 expression [68]. The gene discussed is CD99; the disease is rhabdomyosarcoma.